Abbreviations 4 HNE: 4-Hydroxy-2-Nonenal ACSL-4: Acyl-CoA synthetase long-chain family member 4 AD: Alzheimers Disease AKT: Protein Kinase B AMPK: AMP-activated protein kinase ANOVA: Analysis of Variance cDNA: Complementary DNA CTX: Cerebral cortex CNS: Central Nervous System CPZ: Cuprizone CPZ-DE: Cuprizone-Demyelination CPZ-DE + FIS: Cuprizone-Demyelination + Fisetin CPZ-RE: Cuprizone-Remyelination CPZ-RE + FIS: Cuprizone-Remyelination + Fisetin Ct: Threshold cycle DAB: Diaminobenzidine DMTs: Disease Modifying Therapies EAE: Experimental Autoimmune Encephalomyelitis F: Forward primer FDA: Food and drug administration FIS: Fisetin (3,3,4,7-tetrahydroxyflavone) FTH1: Ferritin Heavy Chain 1 FTL: Ferritin Light Chain GFAP: Glial Fibrillary Acidic Protein GPX4: Glutathione Peroxidase 4 GSH: Glutathione H&E: Hematoxylin and Eosin HC: Hippocampus IL-1: Interleukin- 1 Beta IL-1R: Interleukin-1 receptor iNOS: inducible nitric oxide synthase LFB: Luxol Fast Blue LPO: Lipid Peroxidation LSD: Least Significant Differences MBP: Myelin Basic Protein MCP-1: Monocyte chemoattractant protein-1 MDA: Malondialdehyde MS: Multiple Sclerosis Na CMC: Sodium Carboxymethyl Cellulose NC: Normal Control NCOA4: Nuclear Receptor Coactivator 4 NIH: National Institutes of Health Nrf2: Nuclear factor erythroid 2-related factor 2 Olig-1: Oligodendrocyte Transcription Factor-1 OLs: Oligodendrocytes PB: Prussian Blue PBS: Phosphate Buffered Saline PCR: Polymerase Chain Reaction PD: Parkinsons Disease PI3K: Phosphoinositide 3-kinase PUFAs: Polyunsaturated Fatty Acids qPCR: Quantitative Polymerase Chain Reaction qRT PCR: Quantitative Real Time Polymerase Chain Reaction R: Reverse primer ROS: Reactive oxygen species RQ: Relative quantity RRMS: Relapsing Remitting Multiple Sclerosis SD: Standard Deviation SPMS: Secondary Progressive Multiple Sclerosis SYBR: SYBR Green TBARS: Thiobarbituric Acid Reactive Substances TfR1: Transferrin receptor 1 TLR: Toll-like receptor TST: Tail suspension test References Oh J, Vidal-Jordana A, Montalban X (2018) Multiple sclerosis: clinical aspects
These updates are critical for the Muaythai community to understand, as compliance ensures a fair playing field for all athletes
Hussain et al., 2016)
The participating experts consider the suspicion of the disease by clinicians as a key factor in early recognition and diagnosis, emphasizing an improved awareness of the disease by the first-admission or referring physicians
Galicia-Moreno M, Lucano-Landeros S, Monroy-Ramirez HC, Silva-Gomez J, Gutierrez-Cuevas J, Santos A, Armendariz-Borunda J (2020) Roles of Nrf2 in liver diseases: molecular, pharmacological, and epigenetic aspects
